Laboratory Developed Tests Market Size & Forecast 2034

Laboratory Developed Tests Market - By Technology, By Application, By End Use - Global Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/Country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Technology trends

2.2.3&nbsp;&nbsp;&nbsp; Application trends

2.2.4&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing incidence of cancer and genetic disorders

3.2.1.2&nbsp;&nbsp;&nbsp; Rising prevalence of infectious and chronic diseases

3.2.1.3&nbsp;&nbsp;&nbsp; Growing awareness and focus on early disease detection

3.2.1.4&nbsp;&nbsp;&nbsp; Technological advancements

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Availability of alternative testing methods

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Integration of automation &amp; digital pathology

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.4.1&nbsp;&nbsp;&nbsp; LDT pricing models &amp; strategies

3.4.2&nbsp;&nbsp;&nbsp; Clinical laboratory fee schedule (CLFS) impact analysis

3.4.3&nbsp;&nbsp;&nbsp; Medicare Part B coverage &amp; reimbursement rates

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Technological landscape

3.6.1&nbsp;&nbsp;&nbsp; Current technologies

3.6.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.7&nbsp;&nbsp;&nbsp; Future market trends

3.8&nbsp;&nbsp;&nbsp; Value chain analysis

3.9&nbsp;&nbsp;&nbsp; Consumer behavior analysis

3.10&nbsp;&nbsp;&nbsp; Investment landscape

3.11&nbsp;&nbsp;&nbsp; Pricing analysis, 2024

3.12&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.13&nbsp;&nbsp;&nbsp; PESTEL analysis

3.14&nbsp;&nbsp;&nbsp; Gap analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.3.1&nbsp;&nbsp;&nbsp; North America

4.3.2&nbsp;&nbsp;&nbsp; Europe

4.3.3&nbsp;&nbsp;&nbsp; Asia Pacific

4.3.4&nbsp;&nbsp;&nbsp; LAMEA

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers &amp; acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships &amp; collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Polymerase chain reaction (PCR)

5.3&nbsp;&nbsp;&nbsp; Next-generation sequencing (NGS)

5.4&nbsp;&nbsp;&nbsp; Immunohistochemistry (IHC)

5.5&nbsp;&nbsp;&nbsp; Other technologies

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Oncology

6.3&nbsp;&nbsp;&nbsp; Infectious diseases

6.4&nbsp;&nbsp;&nbsp; Genetic &amp; rare disorders

6.5&nbsp;&nbsp;&nbsp; Cardiology

6.6&nbsp;&nbsp;&nbsp; Autoimmune &amp; inflammatory conditions

6.7&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospital laboratories

7.3&nbsp;&nbsp;&nbsp; Private reference labs

7.4&nbsp;&nbsp;&nbsp; Specialty diagnostic labs

7.5&nbsp;&nbsp;&nbsp; Other end users

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; ARUP Laboratories

9.2&nbsp;&nbsp;&nbsp; BioReference

9.3&nbsp;&nbsp;&nbsp; EXACT SCIENCES

9.4&nbsp;&nbsp;&nbsp; Freenome

9.5&nbsp;&nbsp;&nbsp; GeneDx

9.6&nbsp;&nbsp;&nbsp; GUARDANT

9.7&nbsp;&nbsp;&nbsp; HealthBio

9.8&nbsp;&nbsp;&nbsp; IgX

9.9&nbsp;&nbsp;&nbsp; Labcorp

9.10&nbsp;&nbsp;&nbsp; MAYO CLINIC LABORATORIES

9.11&nbsp;&nbsp;&nbsp; MicroGenDX

9.12&nbsp;&nbsp;&nbsp; prognomiQ

9.13&nbsp;&nbsp;&nbsp; Quest Diagnostics

9.14&nbsp;&nbsp;&nbsp; SONIC HEALTHCARE USA

9.15&nbsp;&nbsp;&nbsp; Veracyte 
&nbsp;

Laboratory Developed Tests Market

Get a free sample of this report